Showing posts with label post. Show all posts
Showing posts with label post. Show all posts
Monday, October 24, 2016
Current Update Genomics CDC ► PRECISION PUBLIC HEALTH NEW CDC BLOG POST
Current Update Genomics CDC ► PRECISION PUBLIC HEALTH NEW CDC BLOG POST
Precision Public Health: Reconciling Biological and Social Determinants of Health | Genomics and Health Impact Blog | Blogs | CDC
PRECISION PUBLIC HEALTH: NEW CDC BLOG POST
Precision Public Health: Reconciling Biological and Social Determinants of Health
Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionOn June 6-7, 2016, I had the honor of participating in the Precision Public Health summit hosted by the Gates Foundation and the White House Office of Science and Technology at the University of California in San Francisco. The summit focused on developing a global precision agenda to improve health and prevent death and disease in the first 1000 days of life, but many of the concepts discussed apply throughout the life span. Experts from around the country explored how big data can be used to ensure that all children have the best opportunity to survive and thrive.
The meeting featured leaders from public health, healthcare, academia, industry, community organizations, philanthropic organizations, as well as patients. The meeting included presentations on several aspects of child health and development as well as focus of infant and child diseases of public health significance. Topics discussed included sudden death, prematurity, asthma, lead poisoning, infectious diseases, newborn screening, and others.
The concept of precision public health is relatively new. Of course, the precision medicine movement has taken off in the past few years, especially with the implementation of the precision medicine initiative in the US. If the goal of precision medicine is to deliver the right health intervention to the right person at the right time, the ultimate goal of precision public health is to develop and implement health interventions that can benefit the right populations at the right time. While implicit in the precision medicine concept is the use of genomic, behavioral, and environmental data in developing new and targeted interventions, more often than not, the discourse is about developing new drugs for treating cancer and other diseases. There is much less emphasis on joining biological with social/environmental determinants of health to develop and implement precision approaches to keep individuals and communities healthy.
For two days, participants heard about examples of increased precision in public health approaches with a clear focus on social and environmental determinants of health. The passion and commitments exhibited by participants were quite impressive. Breakout groups tackled many topics including, among others, building a definition and success criteria for the field of precision public health, engaging communities in precision public health, integrating various sources of environmental data for policy and decision support, and creating a Precision Social Justice Toolkit.
As we eagerly await the summary write-up of this event, I reflect briefly on the three essential elements of precision public health.
Data: As the data deluge continues, we have a unique opportunity to use information from multiple levels both below the skin (genomics, omics, molecules) and above the skin (behavior, environment, place, policies) to have a more coherent picture of determinants of health and disease in each population. As discussed at the meeting, there are ongoing studies (e.g. asthma) and near term opportunities for linking existing data and applying new tools of measurement to get a more complete picture of health and disease in relation to time, place and persons. Better and more precise measurements of environmental and social determinants of health and their interactions with our biology could lead to more focused interventions that are not just drugs, genes and diseases.
Action: One important take home message is that data are not enough! New and more precise population health data should be used to develop and implement actions that can improve health and prevent disease. Actions can include treatments, prevention strategies, policies, and programs. The precision in action will be based on evidence that ties population data to measurable outcomes in subpopulations stratified by persons, place, and time. Action is also multilevel (e.g., individual, family, community, societal) and multisectorial (healthcare, education, housing, etc.) Solving health problems of children (and adults) will involve both the private and public sector using decision support tools and community data to impact health and policy and program decisions.
A focus on equity: A fundamental concern for public health is promoting health equity by reducing health disparities among groups of people. Throughout the summit, there was a focus on addressing health equities in populations both in the US and globally. If precision medicine is to succeed as a movement, its benefits need to reach all segments of society. Starting with equity in mind, population data collected should not only document that inequities exist, but influence actions and solutions to address them. Dr. Sue Desmond-Hellman articulated this emphasis on equity, in her recent TED talk and reiterated again at the summit. For example, on the topic of precision surveillance she said:
lets say, for example, we find out in certain areas of Africa that babies are dying because of a bacterial infection transferred from the mother to the baby,known as Group B streptococcus. In the absence of treatment, mom has a seven times higher chance that her next baby will die. Once we define the problem, we can prevent that death with something as cheap and safe as penicillin. We can do that because then well know. And thats the point: once we know, we can bring the right interventions to the right population in the right places to save lives.
Precision approaches can also be applied to other global health problems, such as malaria, HIV, cervical cancer, and more.
In closing, I believe that precision public health is not a me, too movement that is attempting to divert attention from the important work of precision medicine, but an essential public health partner that can leverage new tools and technologies to measure health in populations and to develop the right interventions that will benefit all segments of society. The work is just getting started to establish collaborative processes, networks, governance and tools to build a strong evidentiary foundation for precision public health.
Categories genomics, public health
Tags precision public healthCurrent|Update|Genomics|CDC
download now
Saturday, September 17, 2016
Post Mass Shooting Programs and Resources Overview
Post Mass Shooting Programs and Resources Overview
aspr-tracie-ta-resources-for-orlando-shooting-incident.pdf
Post-Mass Shooting Programs and Resources Overview
Many communities are trying to recover from the tragic shooting in Orlando, Florida. ASPR Technical Resources, Assistance Center, and Information Exchange (TRACIE) has gathered information on programs and resources that are available to help communities cope with the disaster and answer tough questions as they recover. Learn More >>
download now
Monday, September 5, 2016
A Post Card Between The Pages
A Post Card Between The Pages
"A letter always seemed to me like Immortality."
- Emily Dickinson
I was looking for an old book to read. I found one of my old pocketbooks. I was about to read it when I discovered an old post card between the pages. It was from my college best friend written many years ago. He sent me a post card when he went to Paris on a business trip. Reading the post card again warmed my heart.
http://feeds.feedburner.com/HeartofRachel
download now
Thursday, August 4, 2016
New imaging method may predict risk of post treatment brain bleeding after stroke National Institutes of Health NIH
New imaging method may predict risk of post treatment brain bleeding after stroke National Institutes of Health NIH
New imaging method may predict risk of post-treatment brain bleeding after stroke | National Institutes of Health (NIH)

Institute/Center
National Institute of Neurological Disorders and Stroke (NINDS)
Contact
Barbara McMakin(link sends e-mail)
301-496-5751
New imaging method may predict risk of post-treatment brain bleeding after stroke
NIH scientists develop technique that provides new insight into stroke.

In a study of stroke patients, investigators confirmed through MRI brain scans that there was an association between the extent of disruption to the brains protective blood-brain barrier and the severity of bleeding following invasive stroke therapy. The results of the National Institutes of Health-funded study were published in Neurology.
These findings are part of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE)-2 Study, which was designed to see how MRIs can help determine which patients undergo endovascular therapy following ischemic stroke caused by a clot blocking blood flow to the brain. Endovascular treatment targets the ischemic clot itself, either removing it or breaking it up with a stent.
The blood-brain barrier is a layer of cells that protects the brain from harmful molecules passing through the bloodstream. After stroke, the barrier is disrupted, becoming permeable and losing control over what gets into the brain.
The biggest impact of this research is that information from MRI scans routinely collected at a number of research hospitals and stroke centers can inform treating physicians on the risk of bleeding, said Richard Leigh, M.D., a scientist at NIHs National Institute of Neurological Disorders and Stroke (NINDS) and an author on the study.
In this study, brain scans were collected from more than 100 patients before they underwent endovascular therapy, within 12 hours of stroke onset. Dr. Leigh and his team obtained the images from DEFUSE-2 investigators.
Using a new method of image processing, Dr. Leighs group was able to get detailed measurements on the extent to which the blood-brain barrier is disrupted following a stroke. Combining that data with findings from the DEFUSE-2 study revealed that large degrees of blood-brain barrier disruption were associated with severe bleeding following endovascular therapy. Extensive breakdown of the blood-brain barrier was associated with parenchymal hematoma, a form of bleeding in the brain that carries the greatest risk for the patient. In addition, the results showed a link between the location of blood-brain barrier damage and post-treatment brain bleeding.
Ischemic stroke patients are increasingly receiving combination therapy, endovascular treatment along with an intravenous drug known as tissue plasminogen activator (t-PA), to effectively break up clots in the brain. However, bleeding into the damaged brain tissue is a serious complication of both acute stroke therapies. t-PA has been shown to be most effective when given within a few hours of stroke onset, but the treatment window for endovascular therapy is unknown.
With the growing precision of brain imaging technology, researchers are able to get a detailed look at what is going on in the brain during a stroke. Innovative studies, such as DEFUSE-2, can help patients and their doctors make more informed decisions about medical care, said Walter Koroshetz, M.D., director of NINDS.
According to the authors, examining blood-brain barrier disruption on brain images may potentially help doctors identify patients not likely to benefit from endovascular therapy. It is too early to say how these images will be able to help guide clinical decisions, but they can expand how we think about stroke, especially as we try to broaden treatment options for this disease that can have devastating consequences, said Dr. Leigh.
The DEFUSE-3 trial is currently underway, in which researchers will use imaging data to select patients for endovascular therapy up to 16 hours after stroke onset. The patients recovery will be closely monitored for three months following the treatment.
This study was supported by the NIH (NS039325, NS051372, NIH Intramural Program).
The NINDS is the nations leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institutes of Health (NIH): NIH, the nations medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH
Turning Discovery Into Health®
Reference
R. Leigh et al. Pretreatment bloodbrain barrier disruption and postendovascular intracranial hemorrhage. Neurology, June 17, 2016.download now
Subscribe to:
Posts (Atom)